Comments on: Pharmaceutical Litigation http://goldenbergheller.com Tue, 31 Jan 2012 17:49:25 +0000 hourly 1 http://wordpress.org/?v=3.0.1 By: Asthma and pre-term labor medication Terbutaline warning due to infant brain damage | Goldenberg Heller Antognoli & Rowland http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-103 Asthma and pre-term labor medication Terbutaline warning due to infant brain damage | Goldenberg Heller Antognoli & Rowland Thu, 01 Dec 2011 14:25:17 +0000 http://goldenbergheller.com/?page_id=1000#comment-103 [...] early contractions every year. The use of Terbutaline for use in pre-term labor and premature birth is not approved by the FDA. In fact, in 1997 the FDA issued its first warning concerning the potential dangers associated with [...] [...] early contractions every year. The use of Terbutaline for use in pre-term labor and premature birth is not approved by the FDA. In fact, in 1997 the FDA issued its first warning concerning the potential dangers associated with [...]

]]> By: Bladder Cancer Warning For Diabetes Drug Actos | Goldenberg Heller Antognoli & Rowland http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-100 Bladder Cancer Warning For Diabetes Drug Actos | Goldenberg Heller Antognoli & Rowland Wed, 26 Oct 2011 13:56:07 +0000 http://goldenbergheller.com/?page_id=1000#comment-100 [...] with use of the diabetes drug Actos (pioglitazone), after analysis of a 5-year study of the drug by manufacturer Takeda [...] [...] with use of the diabetes drug Actos (pioglitazone), after analysis of a 5-year study of the drug by manufacturer Takeda [...]

]]> By: Supreme Court decision protects makers of generic drugs | Goldenberg Heller Antognoli & Rowland http://goldenbergheller.com/practice-areas/pharmaceutical-litigation/comment-page-1/#comment-95 Supreme Court decision protects makers of generic drugs | Goldenberg Heller Antognoli & Rowland Thu, 29 Sep 2011 01:39:10 +0000 http://goldenbergheller.com/?page_id=1000#comment-95 [...] a recent 5-4 decision in Pliva v. Mensing, the United States Supreme Court ruled that makers of generic drugs cannot be sued for failing to warn people of potentially dangerous side effects, as long as their [...] [...] a recent 5-4 decision in Pliva v. Mensing, the United States Supreme Court ruled that makers of generic drugs cannot be sued for failing to warn people of potentially dangerous side effects, as long as their [...]

]]>